Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multidrug-resistant gram-negative organisms: A primer on mechanisms of resistance and emerging therapies for the non-infectious diseases clinician

The American Journal of the Medical Sciences(2025)10.1016/j.amjms.2025.10.009Source: DataRank Database

Multidrug-resistant gram-negative organisms: A primer on mechanisms of resistance and emerging therapies for the non-infectious diseases clinician is a research paper published in The American Journal of the Medical Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.30)OA: closedTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Max W. Adelman ORCID,Jesse T. Jacob ORCID,William R. Miller ORCID,R Alfonso Hernandez Acosta ORCID

Live enrichment

PubMed:41115504 OpenAlex:https://openalex.org/W4415355192

National Institute of Allergy and Infectious Diseases

Grant: R21 AI175821

National Institute of Allergy and Infectious Diseases

Grant: R21 AI190338

National Institute of Allergy and Infectious Diseases

Grant: K23 AI185174

National Institutes of Health

FWCI

0.30

Citation Percentile

0.6%

Citation Trend

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0002962925012467?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002962925012467?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.amjms.2025.10.009

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41115504

Fields of Study

Antibiotic Resistance in BacteriaEscherichia coli research studiesUrinary Tract Infections ManagementMedicineHumansDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsGram-Negative BacteriaGram-Negative Bacterial Infectionsbeta-LactamasesAcinetobacter baumanniiCarbapenemsPseudomonas aeruginosa

MeSH Terms

Anti-Bacterial Agentsbeta-LactamasesGram-Negative BacteriaHumansPseudomonas aeruginosaCarbapenemsGram-Negative Bacterial InfectionsDrug Resistance, Multiple, BacterialAcinetobacter baumannii

Keywords

Pseudomonas aeruginosaAntibiotic resistanceAntibioticsPrimer (cosmetics)Resistance (ecology)AcinetobacterGram-negative BacteriaCarbapenem-resistanceΒ-lactamase

Multidrug-resistant gram-negative organisms: A primer on mechanisms of resistance and emerging therapies for the non-infectious diseases clinician

FAIR Checklist

Authors (4)

Funding (4 grants)

Impact

Open Access

Topics